These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 686971)

  • 1. Test dose response in schizophrenia: chlorpromazine blood and saliva levels.
    May PR; Van Putten T; Jenden DJ; Cho AK
    Arch Gen Psychiatry; 1978 Sep; 35(9):1091-7. PubMed ID: 686971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine levels and the outcome of treatment in schizophrenic patients.
    May PR; Van Putten T; Jenden DJ; Yale C; Dixon WJ
    Arch Gen Psychiatry; 1981 Feb; 38(2):202-7. PubMed ID: 7212947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and saliva levels of chlorpromazine and subjective response.
    Van Putten T; May PR; Jenden DJ; Cho AK; Yale C
    Am J Psychiatry; 1980 Oct; 137(10):1241-2. PubMed ID: 7416274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature.
    May PR; Van Putten T
    Arch Gen Psychiatry; 1978 Sep; 35(9):1081-7. PubMed ID: 686970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of chlorpromazine with tricyclic anti-depressants in schizophrenic patients.
    Rasheed A; Javed MA; Nazir S; Khawaja O
    J Pak Med Assoc; 1994 Oct; 44(10):233-4. PubMed ID: 7815685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of pattern of blood chlorpromazine and its metabolite levels and prediction of response to chlorpromazine treatment--studies on the rational pharmacotherapy in schizophrenics (author's transl)].
    Sakurai Y; Nakahara T; Ikenaga H; Takahashi R
    Seishin Shinkeigaku Zasshi; 1978 Jul; 80(7):405-24. PubMed ID: 724820
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of akinesia: plasma chlorpromazine and prolactin levels.
    Van Putten T; May PR; Wilkins JN
    Am J Psychiatry; 1980 Nov; 137(11):1446-8. PubMed ID: 7435684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative report on chlorpromazine and metabolites in plasma, erythrocytes and erythrocyte washings from chronically medicated schizophrenic patients.
    Turano P; March JE; Turner WJ; Merlis S
    J Med; 1972; 3(2):109-20. PubMed ID: 4507068
    [No Abstract]   [Full Text] [Related]  

  • 11. Interpatient variation and significance of plasma levels of chlorpromazine in psychotic patients.
    March JE; Donato D; Turano P; Turner WJ
    J Med; 1972; 3(3):146-62. PubMed ID: 4508254
    [No Abstract]   [Full Text] [Related]  

  • 12. Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats.
    Terry AV; Warner SE; Vandenhuerk L; Pillai A; Mahadik SP; Zhang G; Bartlett MG
    Neuroscience; 2008 Oct; 156(4):1005-16. PubMed ID: 18801413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between plasma concentrations of chlorpromazine and clinical response.
    Rivera-Calimlim L; Gift T; Nasrallah HA; Wyatt RJ; Lasagna L
    Commun Psychopharmacol; 1978; 2(3):215-22. PubMed ID: 699536
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of response to chlorpromazine treatment in schizophrenics.
    Sakurai Y; Nakahara T; Takahashi R
    Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
    Rivera-Calimlim L; Nasrallah H; Strauss J; Lasagna L
    Am J Psychiatry; 1976 Jun; 133(6):646-52. PubMed ID: 5901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.
    Stimmel GL; Falloon IR
    J Clin Psychiatry; 1983 Nov; 44(11):420-2. PubMed ID: 6643405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.